Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 50,000 KRW
Change Today +550.00 / 1.11%
Volume 167.3K
048530 On Other Exchanges
As of 2:29 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

intron biotechnology inc (048530) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/9/15 - 70,400
52 Week Low
11/5/14 - 11,750
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for INTRON BIOTECHNOLOGY INC (048530)

Related News

No related news articles were found.

intron biotechnology inc (048530) Related Businessweek News

No Related Businessweek News Found

intron biotechnology inc (048530) Details

iNtRON Biotechnology, Inc., a bio new drug company, develops, manufactures, and commercializes bio-medicines targeting infectious diseases. The company offers super bacteria drugs, such as Sal 200 and NPA 200; cancer treating drug delivery media; heme-iron supplements, antibiotic alternative products for animals; and various lab reagents and kits, as well as nucleic acid tests for new flu, VRE super bacteria, food poison, and Al. iNtRON Biotechnology, Inc. was founded in 1999 and is headquartered in Seongnam, South Korea.

Founded in 1999

intron biotechnology inc (048530) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

intron biotechnology inc (048530) Key Developments

iNtRON Biotechnology, Inc., Annual General Meeting, Mar 27, 2015

iNtRON Biotechnology, Inc., Annual General Meeting, Mar 27, 2015., at 10:00 Korea Standard Time. Location: 137 Jungwon-gu, Seongnam, Gyeonggi sagimakgol to sangdaewondong, Central indeoseupiah 503 of the 5th. Agenda: To consider the approval of financial statements.

iNtRON Biotechnology, Inc. Proposes Amendments to Articles of Incorporation

iNtRON Biotechnology, Inc. proposed amendments to Articles of Incorporation to be approved at the EGM to be held on December 24, 2014.

iNtRON Biotechnology, Inc., Special/Extraordinary Shareholders Meeting, Dec 24, 2014

iNtRON Biotechnology, Inc., Special/Extraordinary Shareholders Meeting, Dec 24, 2014., at 10:00 Korea Standard Time. Location: Headquarters conference room. Agenda: To approve some changes to the Articles of Incorporation Articles; and to approve the Audit Senior Articles.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
048530:KS 50,000.00 KRW +550.00

048530 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 048530.
View Industry Companies

Industry Analysis


Industry Average

Valuation 048530 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 3,241.9x
TEV/Sales 69.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTRON BIOTECHNOLOGY INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at